Announcement of One Newly By-Elected Independent Director at 2022 General Shareholders' Meeting of Tanvex
· Issued by Tanvex BioPharma, Inc.
Close
Today's Information
Provided by: Tanvex BioPharma, Inc.
SEQ_NO
2
Date of announcement
2022/06/17
Time of announcement
16:48:17
Subject
Announcement of One Newly By-Elected Independent
Director at 2022 General Shareholders' Meeting of Tanvex
Date of events
2022/06/17
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/06/17
2.Elected or changed position (Please enter institutional director,
institutional supervisor, independent director, natural-person director or
natural-person supervisor):independent director
3.Title and name of the previous position holder:N/A
4.Resume of the previous position holder:N/A
5.Title and name of the new position holder:Jang-Yang Chang
6.Resume of the new position holder:Director, Institute of
Biotechnology and Pharmaceutical Research, National Health Research
Institutes, Taiwan.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):new appointment
8.Reason for the change: An independent director by-election at 2022 Annual
General Shareholders' Meeting shall be fill the vacancy of 5th Tanvex
Board of Directors.
9.Number of shares held by the new position holder when elected:0 shares.
10.Original term (from __________ to __________):2021/08/27-2024/08/26
11.Effective date of the new appointment:2022/06/17
12.Turnover rate of directors of the same term:1/9
13.Turnover rate of independent directors of the same term:1/3
14.Turnover rate of supervisors of the same term:N/A
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None
